Child and Adolescent Clinical Psychopharmacology Made Simple: Edition 4
Meer oor hierdie e-boek
This fully revised and updated fourth edition offers new information on sleep disorders, sleep medication, and substance abuse. You’ll also find up-to-date DSM-5 definitions, information regarding teen use of antidepressants and suicidality, attention deficit/hyperactivity disorder (ADHD) and ADHD medications, bipolar disorder, psychotic episodes and eating disorders in children and adolescents, the use of antipsychotics in children and adolescents, non-medication approaches and adjuncts to medications, and how to assess and treat noncompliance and “breakthrough” symptoms.
Also included are fact sheets that clearly delineate frequently prescribed medications for each disorder along with medication side effects and signs of toxicity. For each psychological disorder, the book offers: current diagnostic criteria; treatment indications and contraindications; medication information; and help for monitoring, evaluating, and following up with patients.
Whether you are a pediatrician, parent, therapist, educator, or other health care professional, this is the only resource you need to consult for the most recent information on child and adolescent medications and treatment.
Graderings en resensies
Meer oor die skrywer
John H. O’Neal, MD, is a board-certified psychiatrist who has been in private practice since 1977. He is past chief of the department of psychiatry at Sutter Community Hospital in Sacramento, CA. He is associate clinical professor of psychiatry at the UC Davis School of Medicine, and is a fellow of the American Psychiatric Association. He lectures on depression and psychopharmacology to mental health professionals, employee assistance programs, and the public. O’Neal received his master’s in clinical psychology from Harvard University, and doctor of medicine from the University of Washington.
Mary C. Talaga, RPh, PhD, has been a pharmacist for thirty-nine years, with specialization in psychiatric pharmacy and pharmacy administration. She has extensive experience in health care, and has practiced in a variety of clinical settings. Over her career, she has contributed to the development of best practice guidelines, and has promoted collaborative care models. She has provided training and mentoring to health care professionals, and education to patients and consumers.
Bret A. Moore, PsyD, ABPP, is a board-certified clinical and prescribing psychologist in San Antonio, TX. Over the past twelve years, he has taught graduate-level courses in clinical psychopharmacology for multiple universities and colleges. He is the recipient of the Educator of the Year award from the American Society for the Advancement of Pharmacotherapy, and is a fellow of the American Psychological Association.
